Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
about
CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shockIL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidinIntestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiotaAn inflammatory cascade leading to hyperresistinemia in humansHDL in sepsis - risk factor and therapeutic approachHow the Innate Immune System Senses Trouble and Causes TroubleChronic filarial infection provides protection against bacterial sepsis by functionally reprogramming macrophagesAnti-thrombotic agents derived from snake venom proteinsLipopolysaccharide-induced cyclooxygenase-2 expression in human U937 macrophages is phosphatidic acid phosphohydrolase-1-dependentInhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammationInhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosisHepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in miceAMPK inhibition blocks ROS-NFκB signaling and attenuates endotoxemia-induced liver injuryDistinct Patterns of Wnt3a and Wnt5a Signaling Pathway in the Lung from Rats with Endotoxic ShockNeutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis modelSepsis: in search of cure.Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats.Sisters in arms: myeloid and tubular epithelial cells shape renal innate immunity.Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.Monoacyl lipoteichoic acid from pneumococci stimulates human cells but not mouse cellsQuantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide.Transcriptional profiling of the LPS induced NF-kappaB response in macrophagesVisualization of the molecular dynamics of lipopolysaccharide on the plasma membrane of murine macrophages by total internal reflection fluorescence microscopy.Characterisation of lipid profiles in dogs with parvoviral enteritis.Evaluation of platelet count and its association with plateletcrit, mean platelet volume, and platelet size distribution width in a canine model of endotoxemia.Improvements in endotoxemic syndromes using a disintegrin, rhodostomin, through integrin αvβ3-dependent pathway.Biomarkers in canine parvovirus enteritis.Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.Successful Treatment of Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome with the Addition of LinezolidTularemia induces different biochemical responses in BALB/c mice and common volesDissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory responseIn vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatographyComparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant.Therapeutic effect of Schistosoma japonicum cystatin on bacterial sepsis in mice.Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates.GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophagesSynthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriersSepsis induced by cecal ligation and puncture.
P2860
Q24315988-25088EFD-6019-4E03-8F8E-E26391E70135Q24568204-D05F6A3A-1C1C-4496-B36C-C0CEB85F44A0Q24648039-865DABBB-D9E2-42A1-B0D4-D8394B49DAB7Q24796813-5019A2DD-7A53-43C6-8A30-2E50255C5AB1Q26777964-AAF7983D-E071-4405-9712-9A2A2A4EC65AQ27016140-89CBDCAF-169F-4D6D-8B8E-14547D0E5D37Q27321497-25B7665E-5853-467D-82BE-F252BA63673AQ28074523-1DED8214-4A3E-40B6-B239-C5F5E3B23E7AQ28261638-A65BE26C-5186-4831-88C4-58A1F9E39BBAQ28391533-A7F52AB9-2065-43B4-B0D0-161804882AADQ28484135-F21E1B72-329A-4376-94A0-EBC6A6166550Q28513943-CE60867C-631A-45C8-8720-EC5500DD52F3Q28539140-30D3767A-7117-4C9C-9853-201FD4E040A9Q28546819-9BE26594-4245-4DD0-BE3C-4047FCA7A515Q28572775-A6F13B96-1396-43FC-AC12-282B459161B6Q30251753-830C50EF-7EF5-44D5-932C-F027C1119D40Q30477203-3741A6E1-BFB3-451C-9EA1-F9CBECB236C8Q30539710-E49A6ED9-7DC5-4907-BC41-CDAC4EDE7B47Q30700261-5235C14D-9CB6-4289-987C-92585AF546A7Q31142968-6CE37A0D-B6E5-4414-B155-87FE9E43282CQ31151924-516D8C3D-F449-48FA-9396-EF806962069BQ33240448-C22B85C4-D73C-45B4-BAFB-6E6007E40FF0Q33269185-3895AE60-3EC2-4BCC-9A8E-BD9032680465Q33345315-8EA8E8F1-6A85-49FB-9A83-5C65ECF82252Q33375813-6E353334-FD1E-420A-845C-F1CE844D6B25Q33379875-D394B15A-256C-48DF-A893-04F18E7B92D5Q33393200-67099F26-0117-4360-9F8C-6B15505AA549Q33406366-19D5DB72-618C-44C3-B9EE-3322ACEA8FDBQ33412526-30990295-74BD-4A1A-9A74-E70A44D05215Q33440193-7C37BF11-171D-4959-BA36-80C76FEA500AQ33475166-FF092873-2CE7-484E-A1C2-F13FCD96C79EQ33552294-8DAF52D9-914F-4E06-B6A7-94EE63DF8DB2Q33628873-C2B318B9-9695-4CED-ACA0-0F5258657B9AQ33633363-DB5EF392-508C-4C99-A014-3A2C0B3BE0EFQ33651739-6AD04B70-B444-4E1B-9BEF-9F3DFAC99CBFQ33696686-774EB72E-A554-400A-AA05-D6B95000E3E2Q33714195-0754F6D6-8B6E-4637-8A4F-A78F5EE2D98AQ33768987-21A4976E-8ECD-4EAB-852C-378F76F4849BQ33819711-FDBA50A3-E3B9-4641-91C6-F4CCE4FC2A21Q33844878-81385F68-2F35-44AD-9C03-6F5C558C7B0B
P2860
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@ast
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@en
type
label
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@ast
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@en
prefLabel
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@ast
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@en
P2093
P2860
P1476
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
@en
P2093
Edwin S Van Amersfoort
Johan Kuiper
Theo J C Van Berkel
P2860
P304
P356
10.1128/CMR.16.3.379-414.2003
P407
P577
2003-07-01T00:00:00Z